NEW YORK (GenomeWeb News) – Swedish sample preparation firm Denator today announced it raised SEK25.5 million ($3.8 million) in a sixth round of financing.
CEO Olof Sköld said that the fund will "enable us to strengthen our product development and to meet the need [of] our customers and continue our market expansion."
New investor, Novo Seeds, the early stage investment group of Novo A/S, and venture capital firm Almi Invest had a "major" contribution to the financing, Denator said, adding that existing investors also participated.
In conjunction with the financing, Søren Møller, managing investment director at Novo Seeds is joining Denator's board. The investment is Novo Seeds' first in device instrumentation, he said.